481 related articles for article (PubMed ID: 30862720)
1. EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway.
Shen A; Chen Y; Liu L; Huang Y; Chen H; Qi F; Lin J; Shen Z; Wu X; Wu M; Li Q; Qiu L; Yu N; Sferra TJ; Peng J
Cancer Res; 2019 May; 79(9):2257-2270. PubMed ID: 30862720
[TBL] [Abstract][Full Text] [Related]
2. Pien Tze Huang Inhibits Proliferation of Colorectal Cancer Cells through Suppressing PNO1 Expression and Activating p53/p21 Signaling Pathway.
Cao LJ; Liu LY; Chen YQ; Han YY; Wei LH; Yao MY; Fang Y; Wu MZ; Cheng Y; Sferra TJ; Liu HX; Li L; Peng J; Shen AL
Chin J Integr Med; 2024 Jun; 30(6):515-524. PubMed ID: 38216838
[TBL] [Abstract][Full Text] [Related]
3. p53-targeted lincRNA-p21 acts as a tumor suppressor by inhibiting JAK2/STAT3 signaling pathways in head and neck squamous cell carcinoma.
Jin S; Yang X; Li J; Yang W; Ma H; Zhang Z
Mol Cancer; 2019 Mar; 18(1):38. PubMed ID: 30857539
[TBL] [Abstract][Full Text] [Related]
4. Clinical significance of PNO1 as a novel biomarker and therapeutic target of hepatocellular carcinoma.
Roy SK; Srivastava S; McCance C; Shrivastava A; Morvant J; Shankar S; Srivastava RK
J Cell Mol Med; 2024 May; 28(9):e18295. PubMed ID: 38722284
[TBL] [Abstract][Full Text] [Related]
5. FOXD3, frequently methylated in colorectal cancer, acts as a tumor suppressor and induces tumor cell apoptosis under ER stress via p53.
Xu M; Zhu J; Liu S; Wang C; Shi Q; Kuang Y; Fang X; Hu X
Carcinogenesis; 2020 Sep; 41(9):1253-1262. PubMed ID: 31784734
[TBL] [Abstract][Full Text] [Related]
6. MYC-mediated upregulation of PNO1 promotes glioma tumorigenesis by activating THBS1/FAK/Akt signaling.
Chen X; Guo ZQ; Cao D; Chen Y; Chen J
Cell Death Dis; 2021 Mar; 12(3):244. PubMed ID: 33664245
[TBL] [Abstract][Full Text] [Related]
7. POLR1D promotes colorectal cancer progression and predicts poor prognosis of patients.
Wang M; Niu W; Hu R; Wang Y; Liu Y; Liu L; Zhong J; Zhang C; You H; Zhang J; Lu L; Wei L; Xiao W
Mol Carcinog; 2019 May; 58(5):735-748. PubMed ID: 30582221
[TBL] [Abstract][Full Text] [Related]
8. CTCF promotes colorectal cancer cell proliferation and chemotherapy resistance to 5-FU via the P53-Hedgehog axis.
Lai Q; Li Q; He C; Fang Y; Lin S; Cai J; Ding J; Zhong Q; Zhang Y; Wu C; Wang X; He J; Liu Y; Yan Q; Li A; Liu S
Aging (Albany NY); 2020 Jul; 12(16):16270-16293. PubMed ID: 32688344
[TBL] [Abstract][Full Text] [Related]
9. Celecoxib Inhibits Hepatocellular Carcinoma Cell Growth and Migration by Targeting PNO1.
Dai H; Zhang S; Ma R; Pan L
Med Sci Monit; 2019 Sep; 25():7351-7360. PubMed ID: 31568401
[TBL] [Abstract][Full Text] [Related]
10. Transcription Factor EBF1 Over-Expression Suppresses Tumor Growth
Shen Z; Chen Y; Li L; Liu L; Peng M; Chen X; Wu X; Sferra TJ; Wu M; Lin X; Cheng Y; Chu J; Shen A; Peng J
Front Oncol; 2020; 10():1035. PubMed ID: 32676457
[TBL] [Abstract][Full Text] [Related]
11. microRNA-1827 represses MDM2 to positively regulate tumor suppressor p53 and suppress tumorigenesis.
Zhang C; Liu J; Tan C; Yue X; Zhao Y; Peng J; Wang X; Laddha SV; Chan CS; Zheng S; Hu W; Feng Z
Oncotarget; 2016 Feb; 7(8):8783-96. PubMed ID: 26840028
[TBL] [Abstract][Full Text] [Related]
12. TRIM67 Activates p53 to Suppress Colorectal Cancer Initiation and Progression.
Wang S; Zhang Y; Huang J; Wong CC; Zhai J; Li C; Wei G; Zhao L; Wang G; Wei H; Zhao Z; Yu J
Cancer Res; 2019 Aug; 79(16):4086-4098. PubMed ID: 31239268
[TBL] [Abstract][Full Text] [Related]
13. LACTB, a novel epigenetic silenced tumor suppressor, inhibits colorectal cancer progression by attenuating MDM2-mediated p53 ubiquitination and degradation.
Zeng K; Chen X; Hu X; Liu X; Xu T; Sun H; Pan Y; He B; Wang S
Oncogene; 2018 Oct; 37(41):5534-5551. PubMed ID: 29899406
[TBL] [Abstract][Full Text] [Related]
14. AKR1B10, a transcriptional target of p53, is downregulated in colorectal cancers associated with poor prognosis.
Ohashi T; Idogawa M; Sasaki Y; Suzuki H; Tokino T
Mol Cancer Res; 2013 Dec; 11(12):1554-63. PubMed ID: 24140838
[TBL] [Abstract][Full Text] [Related]
15. CPEB3 inhibits epithelial-mesenchymal transition by disrupting the crosstalk between colorectal cancer cells and tumor-associated macrophages via IL-6R/STAT3 signaling.
Zhong Q; Fang Y; Lai Q; Wang S; He C; Li A; Liu S; Yan Q
J Exp Clin Cancer Res; 2020 Jul; 39(1):132. PubMed ID: 32653013
[TBL] [Abstract][Full Text] [Related]
16. KH-Type Splicing Regulatory Protein Controls Colorectal Cancer Cell Growth and Modulates the Tumor Microenvironment.
Caiazza F; Oficjalska K; Tosetto M; Phelan JJ; Noonan S; Martin P; Killick K; Breen L; O'Neill F; Nolan B; Furney S; Power R; Fennelly D; Craik CS; O'Sullivan J; Sheahan K; Doherty GA; Ryan EJ
Am J Pathol; 2019 Oct; 189(10):1916-1932. PubMed ID: 31404541
[TBL] [Abstract][Full Text] [Related]
17. Decreasing CNPY2 Expression Diminishes Colorectal Tumor Growth and Development through Activation of p53 Pathway.
Yan P; Gong H; Zhai X; Feng Y; Wu J; He S; Guo J; Wang X; Guo R; Xie J; Li RK
Am J Pathol; 2016 Apr; 186(4):1015-24. PubMed ID: 26835537
[TBL] [Abstract][Full Text] [Related]
18. The small molecule AU14022 promotes colorectal cancer cell death via p53-mediated G2/M-phase arrest and mitochondria-mediated apoptosis.
Ryu H; Nam KY; Kim JS; Hwang SG; Song JY; Ahn J
J Cell Physiol; 2018 Jun; 233(6):4666-4676. PubMed ID: 29030986
[TBL] [Abstract][Full Text] [Related]
19. LUCAT1 promotes colorectal cancer tumorigenesis by targeting the ribosomal protein L40-MDM2-p53 pathway through binding with UBA52.
Zhou Q; Hou Z; Zuo S; Zhou X; Feng Y; Sun Y; Yuan X
Cancer Sci; 2019 Apr; 110(4):1194-1207. PubMed ID: 30690837
[TBL] [Abstract][Full Text] [Related]
20. Ribosome assembly factor PNO1 is associated with progression and promotes tumorigenesis in triple‑negative breast cancer.
Li J; Liu L; Chen Y; Wu M; Lin X; Shen Z; Cheng Y; Chen X; Weygant N; Wu X; Wei L; Sferra TJ; Han Y; Chen X; Shen A; Shen A; Peng J
Oncol Rep; 2022 Jun; 47(6):. PubMed ID: 35445733
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
